Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Aug:46:595-598.
doi: 10.1016/j.ajem.2020.11.038. Epub 2020 Nov 24.

Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19

Brendan Barrett  1 , Styve Pamphile  2 , Fan Yang  2 , Farnia Naeem  3 , Jinsung Kim  4 , Jayabhargav Annam  4 , Rachel Borczuk  4 , Shira Yellin  4 , Carly Bass  4 , Sabrina Fowler  4 , Maykl Mosheyev  4 , Yael Jessica Mayer  4 , Benjamin W Friedman  5
Affiliations
Multicenter Study

Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19

Brendan Barrett et al. Am J Emerg Med. 2021 Aug.

Abstract

Background: Inflammatory markers are often elevated in patients with COVID-19. The objective of this study is to assess the prognostic capability of these tests in predicting clinical outcomes.

Methods: This was a retrospective cohort study including all patients at least 16 years old with COVID-19 who were admitted from one of five Emergency Departments between March 6th and April 4th, 2020. We included 1123 laboratory-confirmed cases of COVID-19. We analyzed white blood cell count (WBC), absolute lymphocyte count (ALC), lactate dehydrogenase (LDH), C-reactive protein (CRP), procalcitonin (PCT), D-dimer, ferritin, and erythrocyte sedimentation rate (ESR). We looked at clinical outcomes including death, the need for endotracheal intubation (ETT), the need for renal replacement therapy (RRT), and ICU admission. We report Spearman's ρ2 and statistical significance for each correlation with outcomes. We also report positive predictive value, negative predictive value, sensitivity, specificity, positive likelihood ratios, and negative likelihood ratios.

Results: The mean age of our patient population was 62 (SD 16). Thirty-seven percent of patients self-reported Spanish/Hispanic/Latino ethnicity, 47% reported their race as Black or African-American, and 10% reported their race as non-Hispanic white. Inter-rater reliability was 96%. There was no laboratory value that had both sensitivity and specificity of at least 0.90, or that had a positive predictive value and negative predictive value of at least 0.90, or that had likelihood ratios that could reliably predict a severe course of disease.

Conclusion: Inflammatory markers drawn within 48 h of arrival, though often correlated with clinical outcomes, are not individually highly predictive of which patients in a predominantly older and minority population will die or require intubation, RRT, or ICU admission.

Keywords: COVID-19; Inflammatory markers; Prognosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Flow chart for patient inclusion.
See this image and copyright information in PMC

References

    1. Kermali M., Khalsa R.K., Pillai K., Ismail Z., Harky A. The role of biomarkers in diagnosis of COVID-19 – a systematic review. Life Sci. 2020;254 117788. - PMC - PubMed
    1. Chen W., Zheng K.I., Liu S., Yan Z., Xu C., Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):18. - PMC - PubMed
    1. Potempa L.A., Rajab I.M., Hart P.C., Bordon J., Fernandez-Botran R. Insights into the use of C-reactive protein as a diagnostic index of disease severity in COVID-19 infections. Am J Trop Med Hyg. 2020;103(2):561–563. - PMC - PubMed
    1. Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J., et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. - PMC - PubMed
    1. Ponti G., Maccaferri M., Ruini C., Tomasi A., Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020:1–11. - PMC - PubMed

Publication types